Neuronetics (STIM) EBT (2017 - 2026)

Neuronetics (STIM) has reported EBT for 10 consecutive years, with -$3.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT rose 63.84% year-over-year to -$3.6 million in Q2 2026; TTM through Jun 2026 was -$31.8 million, a 30.39% increase from a year earlier, with the FY2025 full-year figure at -$39.9 million, up 4.77% from the prior year.
• EBT was -$3.6 million for Q2 2026 at Neuronetics, up from -$11.3 million in the prior quarter.
• Over five years, EBT peaked at -$3.6 million in Q2 2026 and troughed at -$13.2 million in Q4 2024.
• A 5-year average of -$9.6 million and a median of -$9.8 million in 2025 frame the typical range for EBT.
• Across the five-year window, EBT plunged 110.96% in 2024 and soared 63.84% in 2026, its largest moves.
• Over 5 years, EBT stood at -$8.9 million in 2022, then gained by 29.85% to -$6.3 million in 2023, then sank by 110.96% to -$13.2 million in 2024, then soared by 44.36% to -$7.4 million in 2025, then jumped by 50.74% to -$3.6 million in 2026.
• The last three EBT figures came in at -$3.6 million (Q2 2026), -$11.3 million (Q1 2026), and -$7.4 million (Q4 2025), per Business Quant data.